share_log

bluebird bio | PRE 14A: Preliminary proxy statements relating to merger or acquisition

bluebird bio | PRE 14A: Preliminary proxy statements relating to merger or acquisition

bluebird bio | PRE 14A：并购重组委托声明
美股SEC公告 ·  09/17 04:08

Moomoo AI 已提取核心信息

bluebird bio, Inc. (bluebird) has announced the filing of a preliminary proxy statement with the U.S. Securities and Exchange Commission (SEC) for its 2024 Annual Meeting of Stockholders. The proxy statement includes proposals for stockholder consideration, such as the election of three Class II directors, advisory votes on executive compensation, and amendments to the company's Certificate of Incorporation for a reverse stock split and officer exculpation provisions. The meeting is scheduled for November 6, 2024, at the company's offices in Somerville, Massachusetts. Stockholders are encouraged to vote their shares prior to the meeting. The proxy materials will be available to stockholders via the Internet at www.proxyvote.com, with instructions for accessing the materials and voting described in the Notice of Internet Availability of Proxy Materials mailed to stockholders. The board has recommended voting in favor of all proposals, including the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
bluebird bio, Inc. (bluebird) has announced the filing of a preliminary proxy statement with the U.S. Securities and Exchange Commission (SEC) for its 2024 Annual Meeting of Stockholders. The proxy statement includes proposals for stockholder consideration, such as the election of three Class II directors, advisory votes on executive compensation, and amendments to the company's Certificate of Incorporation for a reverse stock split and officer exculpation provisions. The meeting is scheduled for November 6, 2024, at the company's offices in Somerville, Massachusetts. Stockholders are encouraged to vote their shares prior to the meeting. The proxy materials will be available to stockholders via the Internet at www.proxyvote.com, with instructions for accessing the materials and voting described in the Notice of Internet Availability of Proxy Materials mailed to stockholders. The board has recommended voting in favor of all proposals, including the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
bluebird bio, Inc.（bluebird）宣布向美国证券交易委员会（SEC）提交了一份初步的代理人声明，用于2024年股东年会。代理人声明包括股东考虑的提案，如选举三名二等董事，对高管薪酬的咨询投票以及修订公司章程以进行逆向股票拆分和董事免责条款。会议定于2024年11月6日在位于马萨诸塞州萨默维尔的公司办公室举行。鼓励股东在会议前投票。代理材料将通过互联网向股东提供，股东将根据寄发给股东的代理材料互联网可用性通知中的说明进行访问材料和投票。董事会建议支持所有提案，包括批准安永会计师事务所作为截至2024年12月31日的独立注册会计师公司。
bluebird bio, Inc.（bluebird）宣布向美国证券交易委员会（SEC）提交了一份初步的代理人声明，用于2024年股东年会。代理人声明包括股东考虑的提案，如选举三名二等董事，对高管薪酬的咨询投票以及修订公司章程以进行逆向股票拆分和董事免责条款。会议定于2024年11月6日在位于马萨诸塞州萨默维尔的公司办公室举行。鼓励股东在会议前投票。代理材料将通过互联网向股东提供，股东将根据寄发给股东的代理材料互联网可用性通知中的说明进行访问材料和投票。董事会建议支持所有提案，包括批准安永会计师事务所作为截至2024年12月31日的独立注册会计师公司。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间